Tanner Pharma Group Executives to Present at 2015 BIO International Convention

Presentations to Focus on Enhancing Access and Commercial Success in Challenging International Markets with Minimal Risk and Investment

CHARLOTTE, N.C.--()--Top executives from Tanner Pharma Group will speak at the largest life-science conference in the world, the 2015 BIO International Convention, scheduled for June 15-18 in Philadelphia. The presentations will provide key insights into enhancing product access and commercialization for pharmaceutical companies in challenging international markets.

On June 16, Carolina Cortez, Director of Tanner Pharma Group’s Licensing, Acquisition and Commercialisation Division (TannerLAC), will present “Overcoming Challenges in the Evolving Latin American Market.” Cortez’s presentation will address the complexities of penetrating the Latin American market through registration and promotion, and discuss solutions to commercializing pharmaceutical, biotech and healthcare products including partnering, licensing and targeted divestitures.

Then on June 17, Joshua Cooper, Director of Corporate Development for Tanner Pharma Group, will present “Enhancing Access; Minimizing Investment.” Cooper will share alternative strategies to unlocking value in lower priority markets where pharmaceutical firms often see demand for products.

With over 12 years of international pharmaceutical experience, as well as fluency in English, Spanish and Portuguese, Cortez has a proven ability to drive value in international markets. Under her leadership, TannerLAC provides pharmaceutical, biotech and healthcare companies with access to emerging markets while minimizing the risk, investment and resources necessary for companies to register, market and maximize sales in Latin America and other international markets.

Previously a member of the Bourne Partners investment banking team, Cooper combines his financial background with his global pharmaceutical commercial experience at Merck Sharpe & Dohme, Novartis, and Valeant. He oversees key strategic and commercial initiatives at Tanner as well as Global Access Programmes, including Named Patient Programmes, Expanded Access Programmes, Compassionate Use Programmes, and Emergency Supply allocations.

Both Tanner Pharma Group presentations will take place at 10 a.m. in the Exhibit Hall at the North Carolina Pavilion, booth 4235. Each 20-minute session will be followed by a 10-minute question and answer period. For more information, feel free to contact CCortez@TannerPharma.com or JCooper@TannerPharma.com directly. Both contacts will also be available for meetings through the BIO One-on-One PartneringTM system.

About Tanner Pharma Group

For over 15 years, Tanner Pharma Group has provided highly specialized pharmaceutical services to its partners around the world. Leading pharmaceutical and biotech companies partner with Tanner Pharma to license and commercialize their products in challenging international markets, develop and manage their Global Access Programmes, and source comparator drugs for clinical trials and bioanalysis. By partnering with Tanner Pharma, manufacturers are able to focus on their primary markets and strategies while ensuring that the services they need will follow a strictly controlled protocol of quality.

Headquartered in Charlotte, N.C., USA, with offices in London, São Paulo and Mexico City, Tanner Pharma Group’s reach extends to Europe, Asia, the Middle East, Australia, Canada and Latin America.

For more information about Tanner Pharma Group, please visit TannerPharma.com.

Contacts

Viridian Marketing
Sarah Clark, 704-724-5394
sclark@viridianmarketing.com

Release Summary

Tanner Pharma Group executives will present at the BIO International Convention on enhancing access and commercial success in challenging international markets with minimal risk and investment.

Contacts

Viridian Marketing
Sarah Clark, 704-724-5394
sclark@viridianmarketing.com